These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 562482)

  • 1. Inhibition of both MAO-A and MAO-B required for the production of hypermotility in mice with the 5HT uptake inhibitors chlorimipramine and femoxetine.
    Lasen JB; Squires RF
    Neuropharmacology; 1977; 16(7-8):485-8. PubMed ID: 562482
    [No Abstract]   [Full Text] [Related]  

  • 2. Potentiation of nialamide-induced hypermotility in mice by lithium and the 5-HT uptake inhibitors chlorimipramine and FG 4963.
    Lassen JB; Squires RF
    Neuropharmacology; 1976 Nov; 15(11):665-8. PubMed ID: 137365
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of 5-HT uptake into neurons and platelets in mice treated chronically with chlorimipramine and femoxetine.
    Buus Lassen J; Lund J; Bechgaard E; Søndergaard I
    Psychopharmacology (Berl); 1979 Aug; 64(2):149-53. PubMed ID: 115034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central and peripheral 5-HT uptake in rats treated chronically with femoxetine, paroxetine, and chlorimipramine.
    Lassen JB; Lund J; Søndergaard I
    Psychopharmacology (Berl); 1980; 68(3):229-33. PubMed ID: 6446724
    [No Abstract]   [Full Text] [Related]  

  • 5. The inhibition of A and B forms of MAO in the production of a characteristic behabioural syndrome in rats after 1-tryptophan loading.
    Squires RF; Lassen JB
    Psychopharmacologia; 1975; 41(2):145-51. PubMed ID: 1171489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of monoamine oxidase inhibition by clorgyline, deprenil or tranylcypromine on 5-hydroxytryptamine concentrations in rat brain and hyperactivity following subsequent tryptophan administration.
    Green AR; Youdim MB
    Br J Pharmacol; 1975 Nov; 55(3):415-22. PubMed ID: 1203627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modification of the effects of 5-methoxy-N,N-dimethyltryptamine on exploratory behavior in rats by monoamine oxidase inhibitors.
    Halberstadt AL; Buell MR; Masten VL; Risbrough VB; Geyer MA
    Psychopharmacology (Berl); 2008 Nov; 201(1):55-66. PubMed ID: 18604652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioural hyperactivity in rats treated with selective monoamine oxidase inhibitors and LM 5008, a selective 5-hydroxytryptamine uptake blocker.
    Ashkenazi R; Finberg JP; Youdim MB
    Br J Pharmacol; 1983 Jul; 79(3):765-70. PubMed ID: 6418248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of serotonin reuptake differentially affects heterosexual behavior of male and female rats.
    Hamburger-Bar R; Rigter H; Dekker I
    Life Sci; 1978 May; 22(20):1827-36. PubMed ID: 672432
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of the selective MAO-A inhibitors brofaromine, clorgyline and moclobemide on human platelet MAO-B activity.
    Gleiter CH; Nilsson E; Mühlbauer B; Antonin KH; Bieck PR
    J Neural Transm Gen Sect; 1992; 89(1-2):129-33. PubMed ID: 1418864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration of dopamine synthesis in rat striatum subsequent to selective type A monoamine oxidase inhibition.
    Schoepp DD; Azzaro AJ
    J Neurochem; 1981 Aug; 37(2):527-30. PubMed ID: 6790675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modification of blood pressure and nictitating membrane response to sympathetic amines by selective monoamine oxidase inhibitors, types A and B, in the cat.
    Finberg JP; Youdim MB
    Br J Pharmacol; 1985 Jun; 85(2):541-6. PubMed ID: 3928010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of clorgyline and deprenil on corticosterone levels in rats.
    Ventura MA
    Eur J Pharmacol; 1982 Jul; 81(3):349-55. PubMed ID: 6214412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions between relatively selective monoamine oxidase inhibitors and an inhibitor of 5-hydroxytryptamine re-uptake, clomipramine.
    Marley E; Wozniak KM
    J Psychiatr Res; 1985; 19(4):597-608. PubMed ID: 3935779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Transformation of mitochondrial monoaminoxidases types A and B].
    Shatemirova KK; Vervkina IV; Gorkin VZ
    Biull Eksp Biol Med; 1977 Jun; 83(6):669-70. PubMed ID: 884293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of tranylcypromine stereoisomers, clorgyline and deprenyl on open field activity during long term lithium administration in rats.
    Smith DF
    Psychopharmacology (Berl); 1976 Oct; 50(1):81-4. PubMed ID: 827767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-induced changes in motor activity after selective MAO inhibition.
    Gianutsos G; Carlson GM; Godfrey JG
    Pharmacol Biochem Behav; 1983 Aug; 19(2):263-8. PubMed ID: 6634874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased total activity in the rat after L-tryptophan plus the monoamine oxidase-A inhibitor amiflamine but not after L-tryptophan plus clorgyline.
    Archer T; Fowler CJ; Fredriksson A; Lewander T; Magnusson O; Mohringe B; Söderberg U
    Br J Pharmacol; 1985 Jul; 85(3):581-90. PubMed ID: 2411326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo.
    Lamensdorf I; Youdim MB; Finberg JP
    J Neurochem; 1996 Oct; 67(4):1532-9. PubMed ID: 8858937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered behavior and alcohol tolerance in transgenic mice lacking MAO A: a comparison with effects of MAO A inhibitor clorgyline.
    Popova NK; Vishnivetskaya GB; Ivanova EA; Skrinskaya JA; Seif I
    Pharmacol Biochem Behav; 2000 Dec; 67(4):719-27. PubMed ID: 11166062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.